Autek China Inc. (SHE:300595)

China · Delayed Price · Currency is CNY

14.45

+0.09 (0.63%)

Apr 29, 2026, 12:44 PM CST

-1.83% (1Y)

Market Cap	12.86B
Revenue (ttm)	1.84B
Net Income (ttm)	465.44M
Shares Out	895.29M
EPS (ttm)	0.52
PE Ratio	27.53
Forward PE	19.04
Dividend	0.15 (1.05%)
Ex-Dividend Date	Nov 5, 2025

Volume	4,760,300
Average Volume	8,402,641
Open	14.16
Previous Close	14.36
Day's Range	14.16 - 14.49
52-Week Range	13.76 - 19.98
Beta	0.78
RSI	49.05
Earnings Date	Aug 20, 2026

About Autek China

Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic and optometry medical devices. Autek China Inc. was incorporated in 2000 and is based in Hefei, China. [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2000

Employees 3,752

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300595

Full Company Profile

Financial Performance

In 2025, Autek China's revenue was 1.86 billion, an increase of 2.62% compared to the previous year's 1.81 billion. Earnings were 479.52 million, a decrease of -16.20%.

Financial Statements

News

There is no news available yet.